D. E. Shaw & Co., Inc. Inari Medical, Inc. Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.3 - $68.06 $376,740 - $530,868	7,800 New	7,800 $506,000
Q3 2022 Nov 14, 2022	BUY	$65.58 - $84.69 $1.06 Million - $1.37 Million	16,120 Added 115.16%	30,118 $2.19 Million
Q2 2022 Aug 15, 2022	BUY	$52.13 - $93.81 $729,715 - $1.31 Million	13,998 New	13,998 $952,000
Q4 2021 Feb 14, 2022	SELL	$76.51 - $93.96 $265,489 - $326,041	-3,470 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$71.29 - $95.99 $4.01 Million - $5.4 Million	-56,288 Reduced 94.19%	3,470 $281,000
Q2 2021 Aug 16, 2021	BUY	$79.62 - $114.85 $1.95 Million - $2.82 Million	24,552 Added 69.74%	59,758 $5.57 Million
Q1 2021 May 17, 2021	SELL	$77.91 - $125.92 $288,189 - $465,778	-3,699 Reduced 9.51%	35,206 $3.77 Million
Q4 2020 Feb 16, 2021	BUY	$60.0 - $87.29 $2.33 Million - $3.4 Million	38,905 New	38,905 $3.4 Million

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.96B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.